v3.22.2
Fair Value Measurements and Investments (Tables)
 9 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
Assets and Liabilities Measured at Fair Value on a Recurring Basis
 Fair Value Measurements
Using Inputs Considered as
 Level 1Level 2
 June 30,
2022		September 30,
2021		June 30,
2022		September 30,
2021
 (in millions)
Assets
Cash equivalents and restricted cash equivalents:
Money market funds
$10,894 $11,779 $— $— 
U.S. government-sponsored debt securities
— — — 100 
U.S. Treasury securities
700 2,400 — — 
Investment securities:
Marketable equity securities
564 490 — — 
U.S. government-sponsored debt securities
— — 15 245 
U.S. Treasury securities
4,920 2,985 — — 
Other current and non-current assets:
Money market funds
4 4 — — 
Derivative instruments
— — 764 410 
Total $17,082 $17,658 $779 $755 
Liabilities
Accrued compensation and benefits:
Deferred compensation liability
$153 $167 $— $— 
Accrued and other liabilities:
Derivative instruments
— — 292 109 
Total $153 $167 $292 $109 
Schedule of Non-Marketable Equity Securities
The following table summarizes the total carrying value of the Company’s non-marketable equity securities held as of June 30, 2022 including cumulative unrealized gains and losses:
June 30,
2022
(in millions)
Initial cost basis$722 
Adjustments:
Upward adjustments810 
Downward adjustments (including impairment)(350)
Carrying amount, end of period$1,182 
Unrealized gains and losses included in the carrying value of the Company’s non-marketable equity securities still held as of June 30, 2022 and 2021 were as follows:
Three Months Ended
June 30,		Nine Months Ended
June 30,
2022202120222021
(in millions)
Upward adjustments$5 $180 $231 $323 
Downward adjustments (including impairment)$(284)$— $(337)$(2)